title: HAART is effective as anti-Kaposi's sarcoma therapy only after remission has been induced by chemotherapy.
authors.forename: E
authors.initials: E
authors.lastname: Vaccher
authors.forename: G
authors.initials: G
authors.lastname: di Gennaro
authors.forename: G
authors.initials: G
authors.lastname: Nasti
authors.forename: S
authors.initials: S
authors.lastname: Juzbasic
authors.forename: U
authors.initials: U
authors.lastname: Tirelli
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D017239:Paclitaxel / Q000008:administration & dosage; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D012514:Sarcoma, Kaposi / Q000188:drug therapy*; D014747:Vinblastine / Q000008:administration & dosage / Q000031:analogs & derivatives; D000077235:Vinorelbine
chemical_list: D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors; D014747:Vinblastine; D017239:Paclitaxel; D000077235:Vinorelbine